MicroRNA in hepatic fibrosis and cirrhosis

Frontiers in Bioscience - Landmark

Volumn 19, Issue 8, 2014, Pages 1418-1424

  Xin, Xuan ^a,b   Zhang, Yongxian ^a   Liu, Xiaohong ^a   Xin, Haixia ^a   Cao, Yongcheng ^a   Geng, Ming ^a  

^a JINAN MILITARY GENERAL HOSPITAL   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Hepatic fibrosis; Hepatocellular carcinoma; Review; Stellate cells

Indexed keywords

MICRORNA;

GENETICS; HEPACIVIRUS; HEPATITIS B VIRUS; HOST PATHOGEN INTERACTION; HUMAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; METABOLISM; PHYSIOLOGY; STELLATE CELL; VIROLOGY; VIRUS HEPATITIS;

CARCINOMA, HEPATOCELLULAR; HEPACIVIRUS; HEPATIC STELLATE CELLS; HEPATITIS B VIRUS; HEPATITIS, VIRAL, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MICRORNAS;

EID: 84904569848     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/4292     Document Type: Article

References (59)

1. Friedman SL: Mechanisms of hepatic fibrogenesis. Gastroenterology 134:1655-1669 (2008) (Pubitemid 351615417)
2. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP: The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 45(4):529-38 (2006) (Pubitemid 44307383)
3. Chen K, Rajewsky N: The evolution of gene regulation by transcription factors and microRNAs. Nat Rev Genet 8(2):93-103 (2007) (Pubitemid 46122839)
4. Bala S, Szabo G: MicroRNA Signature in Alcoholic Liver Disease. Int J Hepatol 2012:498232 (2012)
5. Huebert RC, Jagavelu K, Hendrickson HI, Vasdev MM, Arab JP, Splinter PL, Trussoni CE, Larusso NF, Shah VH: Aquaporin-1 promotes angiogenesis, fibrosis, and portal hypertension through mechanisms dependent on osmotically sensitive microRNAs. Am J Pathol 179(4):1851-60 (2011)
6. Li WQ, Chen C, Xu MD, Guo J, Li YM, Xia QM: The rno-miR-34 family is upregulated and targets ACSL1 in dimethylnitrosamine-induced hepatic fibrosis in rats. FEBS J 278(9):1522-32 (2011)
7. Vuppalanchi R, Liang T, Goswami CP, Janga SC, Chalasani N: Relationship between differential hepatic microRNA expression and decreased hepatic cytochrome P450 3A activity in cirrhosis. PLoS One 8(9):e74471 (2013)
8. Zhang Z, Gao Z, Hu W, Zhang J, Dong L: 3, 3'-Diindolylmethane ameliorates experimental hepatic fibrosis via inhibiting miR-21 expression. Br J Pharmacol 170(3):649-60 (2013)
9. El-Serag HB: Hepatocellular carcinoma. N Engl J Med 365(12):1118-27 (2011)
10. Murakami Y, Yasuda T, Saigo K, Urashima T, Toyoda H, Okanoue T, Shimotohno K: Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues. Oncogene 25(17):2537-45 (2006)
11. Yang L, Ma Z, Wang D, Zhao W, Chen L, Wang G: MicroRNA-602 regulating tumor suppressive gene RASSF1A is overexpressed in hepatitis B virus-infected liver and hepatocellular carcinoma. Cancer Biol Ther 9(10):803-8 (2010)
12. Gui J, Tian Y, Wen X, Zhang W, Jia X, Gao Y: Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) 120(5):183-93 (2011)
13. Bae JS, Kim JH, Pasaje CF, Kim YJ, Shin HD: Association study of genetic variations in microRNAs with the risk of hepatitis B-related liver diseases. Dig Liver Dis 44(10):849-54 (2012)
14. Kim HY, Yoon JH, Lee HS, Kim YJ: MicroRNA-196A-2 polymorphisms and hepatocellular carcinoma in patients with chronic hepatitis B. J Med Virol 86(3):446-53 (2014)
15. Yu SJ, Kim JW, Lee JH, Yoon JH, Kim YJ: Association of a microRNA-323b polymorphism with the persistence of hepatitis B virus infection by the enhancement of viral replication. J Viral Hepat (2013) (Epub ahead of print)
16. Gehrau RC, Mas VR, Villamil FG, Dumur CI, Mehta NK, Suh JL, Maluf DG: MicroRNA signature at the time of clinical HCV recurrence associates with aggressive fibrosis progression post-liver transplantation. Am J Transplant 13(3):729-37 (2013)
17. Augello C, Vaira V, Caruso L, Destro A, Maggioni M, Park YN, Montorsi M, Santambrogio R, Roncalli M, Bosari S: MicroRNA profiling of hepatocarcinogenesis identifies C19MC cluster as a novel prognostic biomarker in hepatocellular carcinoma. Liver Int 32(5):772-82 (2012)
18. Ramachandran S, Ilias Basha H, Sarma NJ, Lin Y, Crippin JS, Chapman WC, Mohanakumar T: Hepatitis C virus induced miR200c down modulates FAP-1, a negative regulator of Src signaling and promotes hepatic fibrosis. PLoS One 8(8):e70744 (2013)
19. Burns DM, D'Ambrogio A, Nottrott S, Richter JD: CPEB and two poly (A) polymerases control miR-122 stability and p53 mRNA translation. Nature 473(7345):105-8 (2011)
20. Castoldi M1, Vujic Spasic M, Altamura S, D'Alessandro LA, Klingmüller U, Fleming RE, Longerich T, Gröne HJ, Benes V, Kauppinen S, Hentze MW, Muckenthaler MU: The liver-specific microRNA miR-122 controls systemic iron homeostasis in mice. J Clin Invest 121(4):1386-96 (2011)
21. Jopling CL1, Yi M, Lancaster AM, Lemon SM, Sarnow P: Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 309(5740):1577-81 (2005) (Pubitemid 41266486)
22. Lendvai G, Kiss A, Kovalszky I, Schaff Z: MicroRNAs in hepatocarcinogenesis. Orv Hetil 153(25):978-89 (2012)
23. Henke JI, Goergen D, Zheng J, Song Y, Schüttler CG, Fehr C, Jünemann C, Niepmann M: microRNA-122 stimulates translation of hepatitis C virus RNA. EMBO J 27(24):3300-10 (2008)
24. Jangra RK, Yi M, Lemon SM: Regulation of hepatitis C virus translation and infectious virus production by the microRNA miR-122. J Virol 84(13):6615-25 (2010)
25. Jopling CL, Schütz S, Sarnow P: Position-dependent function for a tandem microRNA miR-122-binding site located in the hepatitis C virus RNA genome. Cell Host Microbe 4(1):77-85 (2008) (Pubitemid 351944051)
26. Machlin ES, Sarnow P, Sagan SM: Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex. Proc Natl Acad Sci U S A 108(8):3193-8 (2011)
27. Gelley F, Zadori G, Nemes B, Fassan M, Kiss A: MicroRNA profile before and after antiviral therapy in liver transplant recipients for hepatitis C virus cirrhosis. J Gastroenterol Hepatol 29(1):121-7 (2014)
28. Fukuhara T, Kambara H, Shiokawa M, Ono C, Katoh H, Morita E, Okuzaki D, Maehara Y, Koike K, Matsuura Y: Expression of microRNA miR-122 facilitates an efficient replication in nonhepatic cells upon infection with hepatitis C virus. J Virol 86(15):7918-33 (2012)
29. Waidmann O, Köberle V, Brunner F, Zeuzem S, Piiper A, Kronenberger B: Serum microRNA-122 predicts survival in patients with liver cirrhosis. PLoS One 7(9):e45652 (2012)
30. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP, Odenthal M: MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47(4):1223-32 (2008) (Pubitemid 351547908)
31. Köberle V, Kronenberger B, Pleli T, Trojan J, Imelmann E, Zeuzem S, Piiper A, Waidmann O: Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. Eur J Cancer 49(16):3442-9 (2013)
32. Yang S, Wu Y, Wang D, Huang S, Zhang L: Establishment of an experimental method for detecting circulating miRNAs in BDL mice. Clin Exp Med 12(4):273-7 (2012)
33. Clarke JD, Sharapova T, Lake AD, Blomme E, Maher J, Cherrington NJ: Circulating microRNA 122 in the methionine- and choline-deficient mouse model of nonalcoholic steatohepatitis. J Appl Toxicol (2013) (Epub ahead of print)
34. Tsai WC, Hsu SD, Hsu CS, Lai TC, Chen SJ, Hsiao M, Tsou AP: MicroRNA-122 plays a critical role in liver homeostasis and hepatocarcinogenesis. J Clin Invest 122(8):2884-97 (2012)
35. Padgett KA, Lan RY, Leung PC, Lleo A, Dawson K, Ansari AA, Gershwin ME: Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun 32(3-4):246-53 (2009)
36. Banales JM, Sáez E, Uriz M, Sarvide S, Bujanda L, Prieto J, Medina JF, LaRusso NF: Up-regulation of microRNA 506 leads to decreased Cl-/HCO3-anion exchanger 2 expression in biliary epithelium of patients with primary biliary cirrhosis. Hepatology 56(2):687-97 (2012)
37. Jiang J, Gusev Y, Aderca I, Mettler TA, Roberts LR, Schmittgen TD: Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin Cancer Res 14(2):419-27 (2008) (Pubitemid 351226109)
38. Li XD, Li ZG, Song XX, Liu CF: A variant in microRNA-196a2 is associated with susceptibility to hepatocellular carcinoma in Chinese patients with cirrhosis. Pathology 42(7):669-73 (2010)
39. Liang Z, Gao Y, Shi W, Zhai D, Wang Y, Du Z: Expression and significance of microRNA-183 in hepatocellular carcinoma. ScientificWorldJournal 2013:381874 (2013)
40. Pineau P, Volinia S, McJunkin K, Marchio A, Lowe SW, Croce CM, Dejean A: miR-221 overexpression contributes to liver tumorigenesis. Proc Natl Acad Sci U S A 107(1):264-9 (2010)
41. Zhou J, Yu L, Gao X, Hu J, Wang J, Zhu H, Fan J: Plasma microRNA panel to diagnose hepatitis B virus-related hepatocellular carcinoma. J Clin Oncol 29(36):4781-8 (2011)
42. Noetel A, Kwiecinski M, Elfimova N, Huang J, Odenthal M: microRNA are Central Players in Anti- and Profibrotic Gene Regulation during Liver Fibrosis. Front Physiol 3:49 (2012)
43. Marquez RT, Bandyopadhyay S, Wendlandt EB, Keck K, Hoffer BA, Icardi MS, Christensen RN, Schmidt WN, McCaffrey AP: Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab Invest 90(12):1727-36 (2010)
44. Yang D, Gao YH, Tan KB, Li PJ, Zhang Y, Wang G: Inhibition of hepatic fibrosis with artificial microRNA using ultrasound and cationic liposome-bearing microbubbles. Gene Ther 20(12):1140-8 (2013)
45. Brockhausen J, Tay SS, Grzelak CA, Pok S, Shackel N, Gamble J, Vadas M, McCaughan GW: miR-181a mediates TGF-β induced hepatocyte EMT and is dysregulated in cirrhosis and hepatocellular cancer. Liver Int (2014) (Epub ahead of print)
46. Tiao MM, Wang FS, Huang LT, Chuang JH, Kuo HC, Yang YL, Huang YH: MicroRNA-29a protects against acute liver injury in a mouse model of obstructive jaundice via inhibition of the extrinsic apoptosis pathway. Apoptosis 19(1):30-41 (2014)
47. Hyun J, Choi SS, Diehl AM, Jung Y: Potential role of Hedgehog signaling and microRNA-29 in liver fibrosis of IKKβ-deficient mouse. J Mol Histol 45(1):103-12 (2014)
48. Yeligar S, Tsukamoto H, Kalra VK: Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199. J Immunol 183(8):5232-43 (2009)
49. Wu K, Ding J, Chen C, Sun W, Wang C, Li Z, Wu MC, Feng GS, Xie WF, Wang HY: Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Hepatology 56(6):2255-67 (2012)
50. Mann J, Chu DC, Maxwell A, Oakley F, Zhu NL, Tsukamoto H, Mann DA: MeCP2 controls an epigenetic pathway that promotes myofibroblast transdifferentiation and fibrosis. Gastroenterology 138(2):705-14, 714.e1-4 (2010)
51. Lakner AM, Steuerwald NM, Walling TL, Bonkovsky HL, Schrum LW: Inhibitory effects of microRNA 19b in hepatic stellate cell-mediated fibrogenesis. Hepatology 56(1):300-10 (2012)
52. Guo CJ, Pan Q, Jiang B, Chen GY, Li DG: Effects of upregulated expression of microRNA-16 on biological properties of culture-activated hepatic stellate cells. Apoptosis 14(11):1331-40 (2009)
53. He Y, Huang C, Sun X, Long XR, Lv XW, Li J: MicroRNA-146a modulates TGF-beta1-induced hepatic stellate cell proliferation by targeting SMAD4. Cell Signal 24(10):1923-30 (2012)
54. Ogawa T, Iizuka M, Sekiya Y, Yoshizato K, Ikeda K, Kawada N: Suppression of type I collagen production by microRNA-29b in cultured human stellate cells. Biochem Biophys Res Commun 391(1):316-21 (2010)
55. Li J, Zhang Y, Kuruba R, Gao X, Gandhi CR, Xie W, Li S: Roles of microRNA-29a in the antifibrotic effect of farnesoid X receptor in hepatic stellate cells. Mol Pharmacol 80(1):191-200 (2011)
56. Chen C, Wu CQ, Zhang ZQ, Yao DK, Zhu L: Loss of expression of miR-335 is implicated in hepatic stellate cell migration and activation. Exp Cell Res 317(12):1714-25 (2011)
57. Chen L, Charrier A, Zhou Y, Chen R, Brigstock DR: Epigenetic regulation of connective tissue growth factor by MicroRNA-214 delivery in exosomes from mouse or human hepatic stellate cells. Hepatology 59(3):1118-29 (2014)
58. Iizuka M, Ogawa T, Enomoto M, Kawada N: Induction of microRNA-214-5p in human and rodent liver fibrosis. Fibrogenesis Tissue Repair 5(1):12 (2012)
59. Zhang Z, Zha Y, Hu W, Huang Z, Zhang J: The autoregulatory feedback loop of microRNA-21/programmed cell death protein 4/activation protein-1(MiR-21/ PDCD4/AP-1) as a driving force for hepatic fibrosis development. J Biol Chem 288(52):37082-93 (2013)